109 results
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
and data, including inventions (whether patentable or not), discoveries, trade secrets, specifications, instructions, processes, formulae, materials … of [***]. 1.129 “Manufacture” means, with respect to a compound or product, activities directed to the sourcing and purchasing of materials, producing
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, an investigator’s brochure, a sample informed consent form, and other materials.
Clinical trial protocols detail, among other things, the objectives … , for example, because of differences in raw materials or manufacturing processes. For such products, the results of appropriate preclinical or clinical trials
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
on the bridging aspect in the study. This is something that has also recently come up in the advisory committee materials for (inaudible). It looked like bridging
D
AUTL
Autolus Therapeutics plc
23 Feb 24
Exempt offering of security
5:28pm
materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
such materials, the depositary may distribute to holders of ADSs instructions on how to retrieve such materials upon request.
If the depositary timely receives … and legal limitations and the terms of the securities on deposit. We cannot assure you that you will receive voting materials in time to enable you to return
8-K
EX-1.1
wxy6 eadb7
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
5zmceekdp
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.3
rfrupaaa h03uaf
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
3v28hgy9uhnzh 4wxi
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.7
3jhgotth8jcsji3hlmp9
7 Feb 24
Automatic shelf registration
10:00pm
8-K
EX-99.1
9pvw48lx5e
11 Dec 23
Regulation FD Disclosure
8:31am
10-Q
EX-10.1
4jkqbb15
9 Nov 23
Quarterly report
4:18pm
10-Q
u7ilser5s6q4xgf2
9 Nov 23
Quarterly report
4:18pm
6-K
5tdkszcrgr5z5cq
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
mvbyh5frr mu
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
jlv0qas1
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
mbk4ec8hvhqcfwhj
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
sjcu e54mi3
6 Jun 23
Current report (foreign)
8:18am
6-K
xdo7os2sl3h3u0j0
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.2
z0asw3opcrzeq
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm